Resources

  • References


    Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. AIDS Info website. Available at:
    http://aidsinfo.nih.gov/contentfiles/AdultandAdolescentGL.pdf. Updated February 12, 2013. Accessed June 3, 2013.


    HIV/AIDS: The basics. AIDS info website. Available at:
    http://aidsinfo.nih.gov/contentfiles/HIVAIDS%5FtheBasics.pdf. Updated August 2012. Accessed June 3, 2013.


    HIV infection. EBSCO DynaMed website. Available at:
    http://www.ebscohost.com/dynamed. Updated May 21, 2013. Accessed June 3, 2013.


    Montaner JS. Treatment as prevention: a double hat-trick.
    Lancet. 2011 Jul 16;378(9787):208-209.


    National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention. Centers for Disease Control and Prevention website. Available at:
    http://www.cdc.gov/nchstp/od/nchstp.html.
    Updated March 7, 2013. Accessed June 3, 2013.


    Primary HIV infection. EBSCO DynaMed website. Available at:
    http://www.ebscohost.com/dynamed. Updated February 13, 2013. Accessed June 3, 2013.


    Preventing transmission of HIV. AIDS info website. Available at:
    http://aidsinfo.nih.gov/contentfiles/UnderstandingHIVPrevention%5FFS%5Fen.pdf. Updated August 2012. Accessed June 3, 2013.


    Rey D, Krebs M, Partisani M, Hess G, et al. Virologic response of zidovudine, lamivudine, and tenofovir disoproxil fumarate combination in antiretroviral-naive HIV-1-infected patients.
    J Acquir Immune Defic Syndr. 2006;43: 530-534.


    Ross LL, Parkin N, Gerondelis P, et al. Differential impact of thymidine analogue mutations on emtricitabine and lamivudine susceptibility.
    J Acquir Immune Defic Syndr. 2006;43(5):567-570.


    Testing for HIV. AIDS info website. Available at:
    http://aidsinfo.nih.gov/contentfiles/TestingPositive%5FFS%5Fen.pdf. Updated August 2012. Accessed June 3, 2013.


    Workowski KA, Berman S, Centers for Disease Control and Prevention. Sexually Transmitted Diseases Treatment Guidelines, 2010.
    MMWR.
    2010;59(No. RR-12):1-110.


    3/8/2007 DynaMed's Systematic Literature Surveillance
    http://www.ebscohost.com/dynamed: Auvert B, Taljaard D, Lagard E, Sobngwi-Tambekou J, Sitta R, Puren A. Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: the ANRS 1265 Trial.
    PLoS Med.
    2005;2(11):e298. Epub Oct 25, 2005.


    Bailey RC, Moses S, Parker CB, et al. Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial.
    Lancet.
    2007 Feb 24;369(9562):643-656.


    Gray RH, Kigozi G, Serwadda D, et al. Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised trial.
    Lancet.
    2007 Feb 24;369(9562):657-666.


    2/21/2008 DynaMed's Systematic Literature Surveillance
    http://www.ebscohost.com/dynamed: Mallal S, Phillips E, Carosi G, et al. HLA-B5701 screening for hypersensitivity to abacavir.
    N Engl J Med.
    2008;358:568-579.


    6/11/2010 DynaMed's Systematic Literature Surveillance
    http://www.ebscohost.com/dynamed: Del Romero J, Castilla J, Hernando V, Rodríguez C, García S. Combined antiretroviral treatment and heterosexual transmission of HIV-1: cross sectional and prospective cohort study.
    BMJ.
    2010:c2205.

  • Resources

    American Foundation for AIDS Research

    http://www.amfar.org

    Centers for Disease Control and Prevention

    http://www.cdc.gov

  • Canadian Resources

    AIDS Committee of Toronto

    http://www.actoronto.org

    Canadian AIDS Society

    http://www.cdnaids.ca